<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> currently has one of the most rapidly increasing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidences in the United States, with the vast majority of cases occurring on the backdrop of metaplastic epithelium (<z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>The availability of appropriate cell line models is essential for maintaining the pace of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> research and for pre-clinical validation of new therapeutic modalities </plain></SENT>
<SENT sid="2" pm="."><plain>The identity of several of the widely utilized esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines (BIC-1, SEG-1 and TE-7) have recently been called into question </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe the establishment and characterization of a bona fide <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> cell line, JH-EsoAd1, from a patient with Barrett-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The rapid dissemination of this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell line to the <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> research community should help ameliorate the current scarcity of preclinical models in this disease </plain></SENT>
</text></document>